Home/Filings/4/0000899243-20-035381
4//SEC Filing

Byrd John C. 4

Accession 0000899243-20-035381

CIK 0001796129other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 9:14 PM ET

Size

5.1 KB

Accession

0000899243-20-035381

Insider Transaction Report

Form 4
Period: 2020-12-23
Byrd John C.
10% Owner
Transactions
  • Award

    Common Stock

    2020-12-23+1,618,1991,618,199 total
Footnotes (1)
  • [F1]Received pursuant to the Merger Agreement, dated as of September 25, 2020, by and among LifeSci Acquisition Corp. ("LifeSci"), Vincera Pharma, Inc. ("Legacy Vincera") and LifeSci Acquisition Merger Sub, Inc., a wholly-owned subsidiary of LifeSci ("Merger Sub"), pursuant to which Merger Sub merged with and into Legacy Vincera, with Legacy Vincera surviving the merger as a wholly-owned subsidiary of LifeSci (which subsequently changed its name to "Vincera Pharma, Inc.").

Issuer

Vincera Pharma, Inc.

CIK 0001796129

Entity typeother

Related Parties

1
  • filerCIK 0001835066

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 9:14 PM ET
Size
5.1 KB